Key result
In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving alpha(1)-adrenergic receptors and the testicular renin-angiotensin system.
Answers are grounded in this paper and cite their sources.
Potential testosterone suppression by doxazosin requires human confirmation; leaves open clinical relevance for alpha-blocker use.
Men are at greater risk of cardiovascular and renal diseases than women. Several hypertensive rat models also exhibit gender differences in blood pressure. Although the mechanisms responsible for these gender differences are not clear, androgens have been shown to promote hypertension. Testosterone is produced by Leydig cells under the regulation of catecholamines acting through both alpha- and beta-adrenoceptors. Some investigators have postulated a putative role of angiotensin II (Ang II) in modulating the action of gonadotropin in Leydig cells, inhibiting testosterone production. In the present work, we analysed the potential mechanism by which the testicular renin-angiotensin system (RAS) decreases the serum circulating levels of testosterone after the in vivo administration of the long-acting selective alpha(1)-adrenergic receptor antagonist doxazosin. RAS was analysed through assessment of the activity of its proteolytic regulatory enzymes. We can conclude that the testicular testosterone production, at least in rat, is regulated by catecholamines through a mechanism involving alpha(1)-adrenergic receptors and RAS, with a putative role for Ang III. Because doxazosin is usually used as a pharmacological therapy in the treatment of hypertension and benign prostatic hyperplasia, our results could also indicate that its benefits are due, at least in part, to decreased serum circulating levels of testosterone.
No takes yet. Share an insight, caveat, or question.
Chica-Rodríguez et al. (2007) studied this question. Doxazosin was evaluated on Serum circulating levels of testosterone and activity of proteolytic regulatory enzymes of the renin-angiotensin system. In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving alpha(1)-adrenergic receptors and the testicular renin-angiotensin system.
Synapse has enriched 10 related papers. Consider them for comparative context: